Clinical trials
Observational Diabetes Mellitus, Type 2 trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
125 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2007 | 2 |
| 2008 | 4 |
| 2010 | 7 |
| 2011 | 1 |
| 2012 | 3 |
| 2013 | 2 |
| 2014 | 3 |
| 2015 | 2 |
| 2016 | 6 |
| 2017 | 13 |
| 2018 | 5 |
| 2019 | 6 |
| 2020 | 10 |
| 2021 | 9 |
| 2022 | 10 |
| 2023 | 8 |
| 2024 | 8 |
| 2025 | 15 |
| 2026 | 10 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 47 |
| Unknown status | 33 |
| Recruiting | 28 |
| Not yet recruiting | 7 |
| Active, not recruiting | 4 |
| Terminated | 3 |
| Enrolling by invitation | 2 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novo Nordisk A/S | 14 |
| The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | 7 |
| Second Hospital of Shanxi Medical University | 5 |
| Nanjing First Hospital, Nanjing Medical University | 4 |
| Bayer | 3 |
| China Cardiometabolic Registries | 3 |
| Peking University Third Hospital | 3 |
| Ruijin Hospital | 3 |
| Sun Yat-sen University | 3 |
| AstraZeneca | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Diabetes Mellitus, Type 2 | 125 |
| Diabetes Mellitus | 20 |
| Obesity | 13 |
| Cognitive Dysfunction | 7 |
| Insulin Resistance | 7 |
| Metabolic Syndrome | 7 |
| Renal Insufficiency, Chronic | 6 |
| Cardiovascular Diseases | 4 |
| Diabetes Mellitus, Type 1 | 4 |
| Non-alcoholic Fatty Liver Disease | 4 |
Trials
Showing 1 to 25 of 125. Each trial links to its page on Pharma Observatory.
25 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.